Lene Uhrbom

Jiang Y, Marinescu VD, Xie Y, Jarvius M, Haglund C, Maturi, NP, Olofsson S, Lindberg N, Olofsson T, Leijonmarck C, Hesselager G, Alafuzoff I, Fryknäs M, Larsson R, Nelander S, and Uhrbom L. Glioblastoma cell malignancy and drug sensititvity are affected by the cell of origin. Cell Reports, in press. 2017

Sreedharan S, Maturi NP, Xie Y, Sundström A, Jarvius M, Libard S, Alafuzoff I, Weishaupt H, Fryknäs M, Larsson R, Swartling FJ and Uhrbom L. Mouse models of pediatric supratentorial high-grade glioma reveal how cell of origin influences tumor development and phenotype. Cancer Research. November 15, 2016. DOI:10.1158/0008-5472.CAN-16-2482 [Epub ahead of print]

Xie Y, Bergström T, Jiang Y, Johansson P, Marinescu VD, Lindberg N, Segerman A, Wicher G, Niklasson M, Baskaran S, Sreedharan S, Everlien I, Kastemar M, Hermansson A, Elfineh L, Libard S, Holland EC, Hesselager G, Alafuzoff I, Westermark B, Nelander S, Forsberg-Nilsson K, and Uhrbom L. The human glioblastoma cell culture resource: validated cell models representing all molecular subtypes. EbioMedicine. 2015 2 1351-1363

Lindberg N, Jiang Y, Xie Y, Bolouri H, Kastemar M, Olofsson T, Holland EC, and Uhrbom L. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. Journal of Neuroscience. 2014 Oct 29;34(44):14644-51

Lindberg N, Kastemar M, Olofsson T, Smits A, and Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 2009 Jun 11;28(23):2266-2275. Epub 2009 Apr 27